WikiWealth

Home > SWOT Analysis > Albany Molecular Research (AMRI) SWOT Analysis

Weaknesses

Opportunities

Threats

Albany Molecular Research (AMRI) SWOT Analysis Profile

Albany Molecular Research, Inc., founded in 1991, offers drug discovery services to U.S. and international pharmaceutical and bioTechnology companies, such as screening programs, bioanalytical services, and natural product services. Its drug discovery services also include a process of altering the chemical structure of a confirmed hit to identify an improved drug lead, and computer-aided drug discovery services to identify novel hits or leads. Albany Molecular Research also provides chemical development services, analytical services, and quality control. Based in Albany, New York, the company also serves agricultural and fine chemical companies, chemical manufacturers, and research entities. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 4

Threats + Weaknesses = 0

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties.